NCT02609776 2026-04-13CHRYSALISJanssen Research & Development, LLCPhase 1 Active not recruiting751 enrolled 2 FDA
NCT04886804 2026-03-13Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)Boehringer IngelheimPhase 1 Active not recruiting608 enrolled 5 FDA
NCT03212404 2025-02-03Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced CancersCheckpoint Therapeutics, Inc.Phase 1 Active not recruiting272 enrolled 3 FDA